Table 2.
Tumor type | Upstream or downstream molecular | Significance | TXNIP expression | Samples | References |
---|---|---|---|---|---|
Liver cancer | Vitamin D3 | VitaminD3 can increase the expression of TXNIP to inhibit the proliferation of liver cancer cells | Down | Cell lines | (69) |
Liver cancer | ChREBP | ChREBP binds to the upstream promoter region of TXNIP and promote TXNIP's expression | Down | Cell lines, tissue, animal | (70) |
Liver cancer | HBx | X protein promotes the expression of TXNIP | Down | Cell lines, tissue | (71) |
Liver cancer | ROS | overexpression of TXNIP inhibits the proliferation of hepatoma cells by producing of ROS | Down | Cell lines, tissue | (72) |
Pancreatic cancer | miR-224/HIF1 | miR-224 targets the 3'UTR of TXNIP to promote the proliferation and migration of PDAC | Down | Cell lines, tissue | (73) |
Pancreatic cancer | Fbw 7 | FBW7 can inhibit the expression of c-myc in PDAC to inhibit the occurrence and development of tumor | Down | Cell lines, tissue, animal | (74) |
Gastric cancer | TNF-α, NF-κB and COX-2 | Disrupting cell growth | Down | Cell lines, tissue | (75) |
ChREBP, the carbohydrate response element binding protein; ROS, Reactive oxygen species; HIF1, hypoxia-inducible factor; Fbw 7, F-box and WD repeat domain-containing7; TNF-α, TumorNecrosisFactor-α; NF-κB, nuclear factor kappa-B; COX-2, Cyclooxygenase-2.